Evernorth — the Cigna division that oversees the Express Scripts pharmacy benefit manager business — has added an option ... copays for two popular weight-loss drugs, Wegovy and Zepbound, at $200.

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Cigna’s Evernorth has reached new deals with ...

For example, your policy might pay $200 for every day you spend in the hospital ... Both policy types give you cash payments you can use for your deductible, copays, coinsurance or everyday life ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - Wegovy from ...

The Cigna Group (NYSE:CI)'s Evernorth division has ... of-pocket expenses for weight-loss drugs Zepbound and Wegovy to $200. A healthcare team discussing strategies for patient advocacy programs.

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

The Cigna Group (NYSE:CI)’s Evernorth division ... out-of-pocket expenses for weight-loss drugs Zepbound and Wegovy to $200. Beginning in the second half of 2025, the program targets businesses ...

at $200 and counts the spending toward toward annual deductibles, the company announced in a news release Wednesday. The Cigna unit positioned the initiative as a cheaper alternative to cash-pay ...